Discovery of small-molecule inhibitors of RUVBL1/2 ATPase

Gang Zhang1, Feng Wang1, Shan Li1

  • 1Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, United States.

Insights

Researchers identified novel pyrazolo[1,5-a]pyrimidine-3-carboxamide compounds targeting RUVBL1/2 ATPases, crucial in cancer progression. Compound 18 demonstrated significant inhibitory activity, offering a promising lead for new anticancer drug development.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Oncology

Background:

  • RUVBL1 and RUVBL2 are highly conserved AAA ATPases implicated in cancer progression.
  • These ATPases are attractive targets for developing novel anticancer therapeutics.

Purpose of the Study:

  • To identify compounds with inhibitory activity against the RUVBL1/2 complex using docking-based virtual screening.
  • To synthesize and evaluate pyrazolo[1,5-a]pyrimidine-3-carboxamide analogs as potential anticancer agents.

Main Methods:

  • Docking-based virtual screening to identify initial hits.
  • Synthesis of pyrazolo[1,5-a]pyrimidine-3-carboxamide analogs.
  • Enzymatic and cellular assays to determine inhibitory activity.
  • Structure-activity relationship analysis.
  • Mass spectrometry-based proteomic analysis to explore cellular effects.

Main Results:

  • Seven compounds exhibited inhibitory activity against the RUVBL1/2 complex.
  • Compound 18 showed potent inhibition with IC50 values of 6.0 ± 0.6 μM (RUVBL1/2 complex) and 7.7 ± 0.9 μM (RUVBL1).
  • Compound 18 demonstrated significant IC50 values in various cancer cell lines (A549, H1795, HCT116, MDA-MB-231).
  • Structure-activity relationship studies identified key structural features for inhibitory activity.

Conclusions:

  • Compound 18 is a potent inhibitor of the RUVBL1/2 complex and exhibits anticancer activity in multiple cell lines.
  • The pyrazolo[1,5-a]pyrimidine-3-carboxamide scaffold serves as a promising starting point for developing improved anticancer therapeutics.
  • Further structural modifications of compound 18 are warranted to optimize potency, selectivity, and pharmacokinetic properties.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.3K
ATP Driven Pumps III: V-type Pumps01:30

ATP Driven Pumps III: V-type Pumps

V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
4.0K
ATP Driven Pumps I: An Overview01:27

ATP Driven Pumps I: An Overview

ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
8.7K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.5K
Pinching-off of Coated Vesicles01:32

Pinching-off of Coated Vesicles

Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
3.3K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.9K